Findings that BAP1 protein serves as tumour suppression gene in cancers including Mesothelioma

12 September 2018
AMAA was pleased to hear of recent findings from the highly regarded researchers at The University of Texas MD Anderson Cancer Center who recently published a paper outlining the role of the BRCA­ associated protein 1 (BAP1) as a tumour suppression gene in cancers, including mesothelioma.  The researchers found that the gene regulates a form of cell death called ferroptosis, opening up a potential new area of therapy research.
While further research is needed into this area to develop a possible therapy, it is pleasing to note that researchers are taking active strides to progress our knowledge and understanding of the possible treatment and management of mesothelioma.
Every step forward offers patients hope that we are coming closer to better treatment outcomes and also reminds us at AMAA of our important role in lobbying government for research funding and patient centred programs to support our members.
On behalf of all AMAA members we salute the hard working research team at MD Anderson Cancer Centre and look forward to hearing of advances in their research findings for mesothelioma in the future.

BAP1-protein-serves-as-tumor-suppressor-gene-in-kidney-eye-bile-duct-and-mesothelioma-cancers